Male fertility and cancer treatment
Authors:
Jiří Heráček 1,2; Vladimír Sobotka 1,2,3; Eva Kindlová 2,4; Václav Eis 2,5; Michael Urban 1,2
Authors place of work:
Univerzita Karlova v Praze, 3. lékařská fakulta, Urologická klinika
1; Fakultní nemocnice Královské Vinohrady, Praha
2; Pronatal, Praha
3; Univerzita Karlova v Praze, 3. lékařská fakulta, Radioterapeutická a onkologická klinika
4; Univerzita Karlova v Praze, 3. lékařská fakulta, Ústav patologie
5
Published in the journal:
Čas. Lék. čes. 2010; 149: 16-20
Category:
Review Article
Summary
Approximately 15% of men with newly diagnosed cancer are younger than 55 years, and about 26% of them are younger than 20 years. However the most common cause of fertility disorders is oncological treatment itself, the oncological diseases, changes in anatomy, and primary or secondary hormonal insufficiency are also significant factors. The chemotherapy, radiation, or their combination reduce sperm count, impair sperm motility and cause disorders in morphology and DNA integrity. Prognosis of sperm production recovery depends on the type of cancer, stage of the disease, patient age, drug treatment, treatment route and dosage, and pre-treatment male fertility.
Key words:
male infertility, cancer, chemotherapy, radiotherapy, gonadotoxicity, spermatogenesis.
Zdroje
1. Steliarova-Foucher E, Stiller C, Kaatsch P, et al. ACCIS Scientific Committee. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet 2004; 364: 2097–2105.
2. DeVita VT, Hellman S, Rosenberg SA. Cancer: Principles & Practice of Oncology (ed 7). Philadelphia: Lippincott Williams & Wilkins 2004; 936.
3. Stephanie JL, Leslie RS, Ann HP, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 2006; 24: 2917–2930.
4. Chung K, Irani J, Efymow B, et al. Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania. Eur J Obstet Gynecol Reprod Biol 2004; 113: 7–11.
5. Agarwal A, Allamaneni SS. Disruption of spermatogenesis by the cancer disease process. J Natl Cancer Inst Monogr 2005; 34: 9–12.
6. Ho GT, Gardner H, DeWolf WC, et al. Influence of testicular carcinoma on ipsilateral spermatogenesis. J Urol 1992; 148: 821–825.
7. Barr RD, Clark DA, Booth JD. Dyspermia in men with localized Hodgkin’s disease. A potentially reversible, immune-mediated disorder. Med Hypotheses 1993; 40: 165–168.
8. Hallak J, Kolettis PN, Sekhon VS, et al. Cryopreservation of sperm from patients with leukemia: is it worth the effort? Cancer 1999; 85: 1973–1978.
9. Meistrich ML, Vassilopoulou-Sellin R, Lipshultz LI. Adverse effects of treatment: gonadal dysfunction. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. ed. 7. Philadelphia: Lippincott Williams & Wilkins 2005; 2560–2574.
10. Schrader M, Muller M, Straub B, et al. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol 2001; 15: 611–617.
11. Trottmann M, Becker AJ, Stadler T, et al. Semen quality in men with malignant disease before and after therapy and role of cryopreservation. Eur Urol 2007; 52: 355–367.
12. Petersen PM, Andersson AM, Rorth M, et al. Undetectable inhibin B serum levels in men after testicular irradiation. J Clin Endocrinol Metab 1999; 84: 213–215.
13. Magelssen H, Brydoy M, Fossa SD. The effects of cancer and cancer treatments on male reproductive function. Nat Clin Pract Urol 2006; 3: 312–322.
14. Martin R. Human sperm chromosome complements in chemotherapy patients and infertile men. Chromosoma 1998; 107: 523–527.
15. Robbins WA, Meistrich ML, Moore D, et al. Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm. Nat Genet 1997; 16: 74–78.
16. Wyrobek AJ, Schmid TE, Marchetti F, et al. Relative susceptibilities of male germ cells to genetic defects induced by cancer chemotherapies. J Natl Cancer Inst Monogr 2005; 34: 31–35.
17. Winther JF, Boice Jr JD, Mulvihill JJ, et al. Chromosomal abnormalities among offspring of childhood-cancer survivors in Denmark: a population-based study. Am J Hum Genet 2004; 74: 1282–1285.
18. Colpi GM, Contalbi GF, Nerva F, et al. Testicular function following chemo-radiotherapy. Eur J Obstet Gynecol Reprod Biol 2004; 113 (Suppl 1): 2–6.
19. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr 2005; 34: 12–17.
20. Lampe H, Horwich A, Norman A, et al. Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 1997; 15: 239–245.
21. Nalesnik JG, Sabanegh Jr ES, Eng TY, et al. Fertility in men after treatment for stage 1 and 2A seminoma. Am J Clin Oncol 2004; 27: 584–588.
22. Joos H, Sedlmayer F, Gomahr A, et al. Endocrine profiles after radiotherapy in stage I seminoma: impact of two different radiation treatment modalities. Radiother Oncol 1997; 43: 159–162.
23. Classen J, Dieckmann K, Bamberg M, et al. German Testicular Cancer Study Group. Radiotherapy with 16 Gy may fail to eradicate testicular intraepithelial neoplasia: preliminary communication of a dose-reduction trial of the German Testicular Cancer Study Group. Br J Cancer 2003; 88: 828–831.
24. Marmor D, Duyck F. Male reproductive potential after MOPP therapy for Hodgkin’s disease: a long-term survey. Andrologia 1995; 27: 99–106.
25. da Cunha MF, Meistrich ML, Fuller LM, et al. Recovery of spermatogenesis after treatment for Hodgkin’s disease: limiting dose of MOPP chemotherapy. J Clin Oncol 1984; 2: 571–577.
26. Tal R, Botchan A, Hauser R, Yogev L, et al. Follow-up of sperm concentration and motility in patients with lymphoma. Hum Reprod 2000; 15: 1985–1988.
27. Viviani S, Bonfante V, Santoro A, et al. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin’s disease. Cancer J Sci Am 1999; 5: 275–282.
28. Anserini P, Chiodi S, Spinelli S, et al. Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counselling. Bone Marrow Transplant 2002; 30: 447–451.
29. Jacob A, Barker H, Goodman A, et al. Recovery of spermatogenesis following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 277–229.
30. Boyd BG, McCallum SW, Lewis RW, et al. Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment. Urology 2006; 68: 840–844.
31. Mydlo JH, Lebed B. Does brachytherapy of the prostate affect sperm quality and/or fertility in younger men? Scand J Urol Nephrol 2004; 38: 221–224.
32. Daniell HW, Tam EW. Testicular atrophy in therapeutic orchiectomy specimens from men with prostate carcinoma: association with prior prostate bed radiation and older age. Cancer 1998; 83: 1174–1179.
33. Raviv G, Pinthus JH, Shefi S, et al. Effects of intravesical chemotherapy and immunotherapy on semen analysis. Urology 2005; 65: 765–767.
34. Colombo R, Bertini R, Salonia A, et al. Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach. J Urol 2001; 165: 51–55.
35. Mansky P, Arai A, Stratton P, et al. Treatment late effects in long-term survivors of pediatric sarcoma. Pediatr Blood Cancer 2007; 48: 192–199.
36. Longhi A, Macchiagodena M, Vitali G, et al. Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol 2003; 25: 292–296.
37. Hyer S, Vini L, O’Connell M, et al. Testicular dose and fertility in men following I (131) therapy for thyroid cancer. Clin Endocrinol (Oxf) 2002; 56: 755–758.
38. Hermann RM, Henkel K, Christiansen H, et al. Testicular dose and hormonal changes after radiotherapy of rectal cancer. Radiother Oncol 2005; 75: 83–88.
Štítky
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistČlánok vyšiel v časopise
Journal of Czech Physicians
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Spasmolytic Effect of Metamizole
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
Najčítanejšie v tomto čísle
- Male fertility and cancer treatment
- Education in schizophrenia: How patients and their relatives assess the relapse prevention programme PREDUKA
- Assessment of health state and working capacity of people suffering from mental disorders and behaviour disorders
- HOX genes and the limb development in the clinical praxis and in the experiment